Stand 460, February 23-24, 2011, Paris, France
Borealis, a leading provider of chemical and innovative plastics solutions, will present a polyethylene solution for self-administered easy-to-use ampoules to converters and brand owners at Pharmapack 2011 from February 23-24, 2011.
Bormed™ LE6601-PH is the latest addition to Borealis’ range of healthcare application-dedicated Bormed polyolefins combining end-user and manufacturing benefits, set to take the spotlight during the annual pharmaceutical industry event.
Low density polyethylene (LDPE) Bormed LE6601-PH enables the development of transparent, simple to squeeze ampoules that allow users of all ages to dispense their eye, ear and nose drop treatments without professional assistance. The LDPE grade is intended for flexible, disposable ampoules that do not require post-steam sterilisation.
For packaging converters, Bormed LE6601-PH allows trouble-free conversion on standard blow moulding machines as well as blow, fill and seal (BFS) machines. Wall thickness and ampoule weight are easy to control thanks to its optimised molecular weight distribution that produces material with low swell. This allows difficult shapes to be formed and ensures straightforward dosing of material quantity to altogether simplify production of consistent, high quality ampoules.
From an environmental and production efficiency perspective, the easy processing creates less waste and a low energy requirement during extrusion.
The balanced properties of Bormed LE6601-PH make it suitable for use in dip-tubes in pharmaceutical sprays in addition to flexible ampoules. Packaging based on Bormed LE6601-PH can be sterilised using ethylene oxide (EtO) or gamma radiation up to 50 kGy.
Bormed products are manufactured under strict quality conditions on dedicated production lines with change control processes installed. Bormed LE6601-PH complies with European Pharmacopeia (EP) and United States Pharmacopeia (USP) standards and is Drug Master File registered.
The four pillars of Bormed - security of supply; dedicated materials; additional support; and innovation – combine to provide Borealis’ healthcare segment customers with peace of mind regarding quality, availability and regulatory compliance of materials for their pharmaceutical and medical applications.
“In response to strong market demand, we have introduced a new version of Bormed LE6601-PH which supports Borealis’ commitment to broaden its Bormed line with a special focus on BFS applications, ” comments Thierry Chevrier, Borealis Vice President for the Business Unit Moulding. “Bormed LE6601-PH supports the growing interest in solutions for the self-administered medication market. We are pleased to present our product which delivers both end-user and manufacturing benefits to the Pharmapack 2011 audience.”
For more information, please visit borealisgroup.com/healthcare.
Borealis Business Unit Film & Fibre
Borealis’ film and fibre business specialises in supplying advanced polyolefin plastics for the manufacture of film, fibre, coating and thermoforming products. Through foresight and focus on our customers’ needs, Borealis provides innovative solutions that add real value throughout the value chain. With over 50 years of experience and pioneering solutions for the film and fibre industry, Borealis has established a leading position on the film and fibre market across Europe, the Middle East and Asia.
Borealis Business Unit Moulding
Borealis moulding business specialises in supplying advanced polyolefin plastics for injection and blow moulding processing technologies. Through leading technologies such as Borstar and BNT (Borealis Nucleation Technology) and a product portfolio for a wide range of applications such as bottles, thin wall packaging, caps and closures, transport packaging, houseware and healthcare, we have established over 50 years a leading position on the moulding market across Europe, the Middle East and Asia. We believe that customer-driven innovation is the only way to achieve and sustain progress.
Borealis is a leading provider of chemical and innovative plastics solutions that create value for society. With sales of EUR 4.7 billion in 2009, customers in over 120 countries, and 5,200 employees worldwide, Borealis is owned 64% by the International Petroleum Investment Company (IPIC) of Abu Dhabi and 36% by OMV, the leading energy group in the European growth belt. Borealis is headquartered in Vienna, Austria, and has production locations, innovation centres and customer service centres across Europe and the Americas.
Through Borouge, a joint venture between Borealis and the Abu Dhabi National Oil Company (ADNOC), one of the world's major oil and gas companies, the company's footprint reaches out to the Middle East, Asia Pacific, the Indian sub-continent and Africa.. Established in 1998, Borouge employs approximately 1,600 people, has customers in more than 50 countries and its headquarters are in Abu Dhabi in the UAE and Singapore.
Building on Borealis' unique Borstar® technology and their experience in polyolefins of more than 50 years, Borealis and Borouge provide innovative, value creating plastics solutions for the infrastructure (pipe systems and power and communication cables), automotive and advanced packaging markets. In addition, Borealis offers a wide range of base chemicals from melamine and plant nutrients to phenol and acetone.
Today, Borealis (borealisgroup.com)and Borouge (borouge.com) have a manufacturing capacity of over 5.4 million tonnes of polyolefins (polyethylene and polypropylene) per year of which 26% are the result of a recently completed capacity expansion in Abu Dhabi. An additional 2.5 million tonnes per year is scheduled for completion by the end of 2013, creating the world's largest integrated polyolefins plant. The companies continue to invest to ensure that their customers throughout the value chain, around the world, can always rely on superior products and security of supply.
Borouge and Borealis are committed to the principles of Responsible Care® and proactively contribute to addressing the world's water and sanitation challenges through their Water for the World™ (waterfortheworld.net) initiative.
Bormed is a trademark of the Borealis group.